Get the Stockscreener App
1.255
5.64%
-0.075
Biosig Technologies Inc stock is currently priced at $1.255, with a 24-hour trading volume of 100.24K.
It has seen a -5.64% decreased in the last 24 hours and a +2.87% rose in the past month.
The chart indicates a potential bearish trend, as the stock is below the $1.37 pivot point. If it approaches the $1.23 support level, significant changes may occur.
Previous Close:
$1.33
Open:
$1.31
24h Volume:
100.24K
Market Cap:
$15.43M
Revenue:
$283.00K
Net Income/Loss:
$-29.95M
P/E Ratio:
-2.2411
EPS:
-0.56
Net Cash Flow:
$-18.73M
1W Performance:
-36.93%
1M Performance:
+2.87%
6M Performance:
+251.25%
1Y Performance:
-7.04%
1D Range:
$1.2536
$1.40
52W Range:
$0.1662
$2.98
Biosig Technologies Inc Stock (BSGM) Company Profile
Name
Biosig Technologies Inc
Sector
Industry
Phone
203 409 5444
Address
55 Greens Farms Road, 1st Floor, Westport, CT
Biosig Technologies Inc Stock (BSGM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-30-20 | Initiated | ROTH Capital | Buy |
Biosig Technologies Inc Stock (BSGM) Latest News
BioSig Technologies, Inc. Announces New Appointments to its Now Fully Constituted Board of Directors, which is Comprised of 5 Board Members, 3 Independent
GlobeNewswire Inc.
BioSig Technologies, Inc. Appoints Mr. Anthony Amato to Position of Chief Executive Officer, Effective Immediately
GlobeNewswire Inc.
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
Why Ascent Solar Technologies Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga
Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket
Benzinga
Biosig Technologies Inc Stock (BSGM) Financials Data
Biosig Technologies Inc (BSGM) Revenue 2024
BSGM reported a revenue (TTM) of $283.00 thousand for the quarter ending March 31, 2023, a -14.50% decline year-over-year.
Biosig Technologies Inc (BSGM) Net Income 2024
BSGM net income (TTM) was -$29.95 million for the quarter ending September 30, 2023, a -4.22% decrease year-over-year.
Biosig Technologies Inc (BSGM) Cash Flow 2024
BSGM recorded a free cash flow (TTM) of -$18.73 million for the quarter ending September 30, 2023, a +20.58% increase year-over-year.
Biosig Technologies Inc (BSGM) Earnings per Share 2024
BSGM earnings per share (TTM) was -$4.80 for the quarter ending September 30, 2023, a +36.00% growth year-over-year.
Biosig Technologies Inc Stock (BSGM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| LONDONER KENNETH L | Chief Executive Officer |
Jun 12 '23 |
Buy |
1.17 |
6,000 |
7,040 |
2,491,420 |
| LONDONER KENNETH L | Chief Executive Officer |
Jun 02 '23 |
Buy |
1.37 |
4,600 |
6,292 |
2,485,420 |
| LONDONER KENNETH L | Chief Executive Officer |
May 31 '23 |
Buy |
1.57 |
8,000 |
12,560 |
2,480,820 |
About Biosig Technologies Inc
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.
4.77%
Cap:
|
Volume (24h):